Tag: CBT > Medical Cannabis Research Cannabinoids: Page 3

Legislation and Regulation

U.S. Senate Passes Legislation to Expand Cannabis Research

The bill, S. 253, would expand scientific and medical research on cannabis and its compounds, including CBD.

March 28, 2022

Nevada

Gb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitis

This new patent covers receptor-targeted formulations for the treatment of cardiac hypertrophy, TRPV1-receptor-associated hearing loss and urinary cystitis.

March 1, 2022

International

Flora Growth Pursues Research on Cannabinoid-Based COVID-19 Treatment in Colombia

The cultivation company wants to research its patent-pending treatment to gauge “all the potential mechanisms of cannabinoids in preventing infection from the SARS-CoV-2 (COVID-19) virus.”

February 7, 2022

Industry Headlines

NFL Awards $1 Million to Universities to Study the Impact of Cannabis, CBD on Pain Management

The funding has been awarded to two teams of medical researchers at the University of California San Diego and the University of Regina.

February 2, 2022

Mississippi

University of Mississippi Launches National Center for Cannabis Research and Education

The new facility will conduct scientific research, data analysis, education and training on the health effects of cannabis.

February 2, 2022

Hemp Research

Preliminary Studies Show Cannabinoids Could Ward Off COVID-19. Will They Live Up to Their Potential?

Recent research from several universities highlights the promise of cannabinoids in fighting off coronavirus through various phases of infection, but experts warn the studies are still too preliminary to draw conclusions.

January 24, 2022

Utah

Pfizer Enters $6.7-Billion Acquisition Deal With Cannabis Pipeline

The American multinational pharmaceutical and biotechnology company signed an agreement with clinical-stage company Arena Pharmaceuticals.

December 21, 2021

International

Global Companies Expand Work on Cannabis-Based Epilepsy Treatments

Representatives of companies with global footprints discuss the goals behind the research, governmental approval and sale of cannabis compounds for epileptic conditions.

December 3, 2021

Top Stories

The Problem with 'Indica' and 'Sativa' on Cannabis Labels: New Report

Genetic testing reveals that those terms don’t correlate in any meaningful way with the effect of the plant’s chemistry.

October 20, 2021

Home

THC-O Acetate: ‘Potent is Not Necessarily Better’

Renowned cannabis and endocannabinoid researcher Dr. Ethan Russo weighs in on the realities and legalities of the cannabinoid THC-O acetate.

September 8, 2021

California

Clever Leaves and Biopharmaceutical Research Company to Partner for Landmark Cannabis Research Study in Collaboration With University of California, Davis

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the company’s first funded study with a research institution in the U.S.

July 27, 2021

Nevada

‘This is Going to Change the Way People Think About Medicine’: Q&A with Dr. Andrea Small-Howard

Chief Science Officer and recently appointed GB Sciences President Dr. Andrea Small-Howard details the company’s latest research in cannabis-based treatments for Parkinson’s disease and pain, and how it is using AI technology to bring novel medicines to market.

July 19, 2021